Skip to main content
TipRanks
Go Ultimate75% OFF

Moderna (MRNA) Revenue by Segment

19,107 Followers

Revenue by Segment

In Q3 2026, Moderna reported revenue by segment of $1.27B (Product Sales) and $40.00M (Grant and Collaboration).

Breaks down revenue across different business areas, revealing which segments are driving growth and how diversified Moderna's income streams are, indicating stability and strategic focus.

$0.00$2.00B$4.00B$6.00BMar 21Jun 21Sep 21Dec 21Mar 22Jun 22Sep 22Dec 22Mar 23Jun 23Sep 23Dec 23Mar 24Jun 24Sep 24Dec 24Mar 25Jun 25Sep 25Dec 25Mar 26Jun 26Sep 26
Chart Insights

Product sales have shifted from pandemic-era scale to a seasonally lumpy, campaign-driven revenue stream that now hinges on respiratory launches, procurement timing and uptake; grant & collaboration income is small and immaterial to revenue volatility. Management’s reiterated growth target and recent market-share gains for mNEXSPIKE point to improving commercial traction, but near-term upside is constrained by seasonal concentration (Q3 importance), assumed non‑contribution from certain products, and a large litigation cash hit—expect uneven quarters tied to regulatory milestones and vaccine seasonality.

MRNA Revenue by Segment

PeriodProduct SalesGrant and Collaboration
Q3 2026Sep 30, 2026$1.27B$40.00M
Q2 2026Jun 30, 2026$94.00M$51.00M
Q1 2026Mar 31, 2026$352.00M$37.00M
Q4 2025Dec 31, 2025$645.00M$33.00M
Q3 2025Sep 30, 2025$973.00M$43.00M
Q2 2025Jun 30, 2025$114.00M$28.00M
Q1 2025Mar 31, 2025$86.00M$22.00M
Q4 2024Dec 31, 2024$938.00M$28.00M
Q3 2024Sep 30, 2024$1.82B$42.00M
Q2 2024Jun 30, 2024$184.00M$57.00M
Q1 2024Mar 31, 2024$167.00M$0.00
Q4 2023Dec 31, 2023$2.79B$18.00M
Q3 2023Sep 30, 2023$1.76B$74.00M
Q2 2023Jun 30, 2023$293.00M$51.00M
Q1 2023Mar 31, 2023$1.83B$34.00M
Q4 2022Dec 31, 2022$4.89B$225.00M
Q3 2022Sep 30, 2022$3.12B$244.00M
Q2 2022Jun 30, 2022$4.53B$218.00M
Q1 2022Mar 31, 2022$5.92B$141.00M
Q4 2021Dec 31, 2021$6.93B$276.00M
Q3 2021Sep 30, 2021$4.81B$159.00M
Q2 2021Jun 30, 2021$4.20B$157.00M
Q1 2021Mar 31, 2021$1.73B$204.00M
Q4 2020Dec 31, 2020$199.87M$370.22M
Q3 2020Sep 30, 2020$0.00$157.91M
Q2 2020Jun 30, 2020$0.00$67.00M
Q1 2020Mar 31, 2020$0.00$8.39M

Related KPIs